NCT03063021View on ClinicalTrials.gov

The FIGHT-RP1 Study

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

February 11, 2019

Study Completion Date

February 11, 2019

Conditions
Retinitis Pigmentosa
Interventions
DRUG

N-Acetyl Cysteine (NAC)

Oral tablets of N-acetyl-cysteine

Trial Locations (1)

21287

Wilmer Eye Institute, Johns Hopkins, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03063021 - The FIGHT-RP1 Study | Biotech Hunter | Biotech Hunter